Combivir
This article has been nominated to be checked for its neutrality. Discussion of this nomination can be found on the talk page. (October 2009) |
| Combination of | |
|---|---|
| Lamivudine | Nucleoside analogue reverse transcriptase inhibitor |
| Zidovudine | Nucleoside analogue reverse transcriptase inhibitor |
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | Oral |
| Legal status | |
| Legal status | |
| Identifiers | |
| ATC code | J05AR01 (WHO) |
| PubChem | CID 160352 |
| ChemSpider | 21106283 |
Combivir is the brand name for a pharmaceutical treatment for HIV infection. It is a fixed dose combination of two antiretroviral drugs, lamivudine (also called 3TC, with the brand name Epivir) and zidovudine (also called AZT, with the brand name Retrovir). The combination of the two drugs has a stronger and more sustained effect than using either drug alone, and assists in reducing pill burden and in aiding compliance with the antiretroviral drug therapy.
Both lamivudine and zidovudine are reverse transcriptase inhibitors, which block the action of an enzyme, reverse transcriptase, that the virus requires for reproduction. It reduces the viral load in the body and raises CD4 cell count.
It was approved for use in the United States by the Food and Drug Administration on September 26, 1997, making it the thirteenth approved antiretroviral. It is marketed by GlaxoSmithKline.
Combivir has some rather unpleasant side effects. Users typically report feeling tired and sick.
External links
- Combivir website operated by GlaxoSmithKline
| 40px | This medical treatment-related article is a stub. You can help ssf by expanding it. |
- Pages with script errors
- Pages with broken file links
- NPOV disputes from October 2009
- Articles with invalid date parameter in template
- Drugs that are a combination of chemicals
- Infobox drug tracked parameters
- Infobox drug articles with contradicting parameter input
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Fixed dose combination (antiretroviral)
- World Health Organization essential medicines
- Medical treatment stubs
- 2Fix
